Evidence map›Paper›PMID 42180355›Full record

ArticlemedRxiv : the preprint server for health sciences2026

Racial and Socioeconomic Disparities in Blood Pressure Control Before and After Intracerebral Hemorrhage.

Samuel Namian, Joel Smith, Sofia Constantinescu, Yome Tawaldermedhen, Santiago Clocchiatti-Tuozzo, Cyprien A Rivier, Shufan Huo, Kane Wu, Victor Torres Lopez, Sanjula Dhillon Singh and 7 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Samuel NamianDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0003-0678-1605
Joel SmithDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.
Sofia ConstantinescuDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0009-0005-0272-4170
Yome TawaldermedhenDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.
Santiago Clocchiatti-TuozzoDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0001-5377-434X
Cyprien A RivierDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0002-1148-1829
Shufan HuoDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0002-0119-7517
Kane WuDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0002-6110-8336
Victor Torres LopezDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0002-2107-2922
Sanjula Dhillon SinghBrain Care Labs, Department of Neurology, Mass General Brigham, Boston, MA, USA.
Christopher D AndersonBrain Care Labs, Department of Neurology, Mass General Brigham, Boston, MA, USA.ORCID 0000-0002-3856-9775
Jonathan RosandBrain Care Labs, Department of Neurology, Mass General Brigham, Boston, MA, USA.ORCID 0000-0002-1014-9138
Seyedmehdi PayabvashDepartment of Radiology, Columbia University Irving Medical Center, New York, NY, USA.ORCID 0000-0003-4628-0370
Santosh MurthyDepartment of Neurology, Weill Cornell Medicine, New York, NY, USA.ORCID 0000-0001-5884-524X
Kevin N ShethDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.
Adam de HavenonDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0001-8178-8597
Guido J FalconeDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0002-6407-0302

Funding

Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)U01NS106513 · NINDS · YALE UNIVERSITY · PI Hooman Kamel, Kevin Navin Sheth · 2019 to 2026
$20.6M
Recurrent Hemorrhagic Stroke in Minority PopulationsR01NS093870 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI JONATHAN ROSAND, Amytis Towfighi · 2016 to 2026
$12.3M
Cilostazol for Prevention of Recurrent Stroke (CLARITY)UG3NS133209 · NINDS · STANFORD UNIVERSITY · PI DE HAVENON, ADAM H., LANSBERG, MAARTEN G · 2025 to 2025
$5.7M
CAPTIVA-MRIUH3NS130228 · NINDS · YALE UNIVERSITY · PI Sepideh Amin-Hanjani, Arindam Rano Chatterjee · 2025 to 2026
$2.8M
REACH-EpiVCIDRF1NS139183 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI ANDERSON, CHRISTOPHER DAVID, ROSAND, JONATHAN · 2024 to 2024
$2.4M
Blood Pressure Variability and Ischemic Stroke Outcome (BP-VISO)R01NS130189 · NINDS · YALE UNIVERSITY · PI Adam H. de Havenon · 2023 to 2026
$2.0M
Anticoagulation in Intracerebral Hemorrhage Survivors with Atrial Fibrillation and Imaging Features of Cerebral Amyloid Angiopathy and Small Vessel DiseaseR01NS140459 · NINDS · YALE UNIVERSITY · PI Guido Jose Falcone, Santosh Bhaskar Murthy · 2025 to 2026
$1.2M
Measuring Brain Health Using Low-Field Portable MRIR21NS138995 · NINDS · YALE UNIVERSITY · PI DE HAVENON, ADAM H. · 2024 to 2024
$477k
NINDS NIH HHS R01 NS093870NINDS NIH HHS R01 NS130189NINDS NIH HHS R01 NS140459NINDS NIH HHS R21 NS138995NINDS NIH HHS RF1 NS139183NINDS NIH HHS U01 NS106513NINDS NIH HHS UG3 NS133209NINDS NIH HHS UH3 NS130228
6 · The paper itself

Abstract

Background: Hypertension is the most potent modifiable risk factor for recurrent intracerebral hemorrhage (ICH), yet blood pressure (BP) control after ICH remains suboptimal, particularly among disadvantaged racial and socioeconomic groups. To what extent post-ICH BP disparities reflect pre-existing hypertension inequities versus differences in post-ICH management is unknown. We examined disparities in BP control before and after ICH, assessed whether post-ICH care differentially improves BP across groups and whether post-ICH disparities persist after accounting for pre-existing BP differences. Methods: We performed a case-only study in the All of Us Research Program, identifying ICH survivors using electronic health record diagnosis codes. Mean systolic BP was calculated for pre-ICH (1-365 days before) and post-ICH (30-365 days after) windows. Neighborhood deprivation tertiles were calculated using 3-digit ZIP codes. The primary outcome was uncontrolled BP (≥140 mmHg). Logistic regression estimated odds of uncontrolled BP, and mediation analysis estimated the proportion of post-ICH disparities explained by pre-ICH BP. Results: Among 2,226 ICH survivors (mean age 60; 50.6% female), 1,760 had pre-ICH and 1,852 had post-ICH BP data. Uncontrolled BP was more common in Black than White survivors both pre-ICH (38.9% vs 21.4%; p<0.001) and post-ICH (34.3% vs 16.3%; p<0.001), and in Deprived versus Privileged neighborhoods post-ICH (23.7% vs 15.8%; p<0.001). In adjusted models, Black race (OR 3.51; 95% CI 2.55-4.83; p<0.001) and Deprived neighborhoods (OR 1.38; 95% CI 1.00-1.91; p=0.048) were associated with uncontrolled post-ICH BP. Among survivors uncontrolled before ICH, 67% of White but only 45% of Black survivors achieved control afterward (p=0.001). Adjusting for pre-ICH BP control status only modestly attenuated the Black-White disparity (OR 4.05 to 2.95; P<0.001). In mediation analyses, pre-ICH BP explained only 27% of the racial (P<0.001) and 26% of the deprivation (P=0.014) disparity. Conclusions: Racial and socioeconomic disparities in BP control persist after ICH, but most post-ICH disparities are not explained by pre-existing inequalities. More advantaged populations achieve greater BP improvement, suggesting effective post-ICH management exists but does not reach all patients equitably. Targeted interventions addressing barriers to post-ICH BP control in disadvantaged populations may substantially reduce persistent disparities.

Identifiers

PMID42180355
PMCPMC13193158

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.